Everence Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,040
| Closed | -$681K | – | 854 |
|
|
2025
Q1 | $681K | Buy |
+3,040
| New | +$681K | 0.05% | 295 |
|
|
2024
Q4 | – | Sell |
-2,130
| Closed | -$639K | – | 1050 |
|
|
2024
Q3 | $639K | Hold |
2,130
| – | – | 0.04% | 346 |
|
|
2024
Q2 | $761 | Hold |
2,130
| – | – | 0.05% | 271 |
|
|
2024
Q1 | $843 | Sell |
2,130
-1,150
| -35% | -$455 | 0.06% | 267 |
|
|
2023
Q4 | $1.16M | Buy |
3,280
+2,020
| +160% | +$711K | 0.08% | 205 |
|
|
2023
Q3 | $473 | Hold |
1,260
| – | – | 0.04% | 400 |
|
|
2023
Q2 | $422K | Hold |
1,260
| – | – | 0.03% | 402 |
|
|
2023
Q1 | $437 | Hold |
1,260
| – | – | 0.04% | 408 |
|
|
2022
Q4 | $297 | Sell |
1,260
-1,230
| -49% | -$290 | 0.03% | 551 |
|
|
2022
Q3 | $613K | Hold |
2,490
| – | – | 0.06% | 289 |
|
|
2022
Q2 | $753K | Hold |
2,490
| – | – | 0.07% | 237 |
|
|
2022
Q1 | $1.02M | Hold |
2,490
| – | – | 0.08% | 206 |
|
|
2021
Q4 | $1.17M | Hold |
2,490
| – | – | 0.09% | 197 |
|
|
2021
Q3 | $1.06M | Hold |
2,490
| – | – | 0.09% | 192 |
|
|
2021
Q2 | $894K | Hold |
2,490
| – | – | 0.07% | 224 |
|
|
2021
Q1 | $702K | Hold |
2,490
| – | – | 0.06% | 252 |
|
|
2020
Q4 | $705K | Buy |
2,490
+1,060
| +74% | +$300K | 0.07% | 240 |
|
|
2020
Q3 | $393K | Buy |
+1,430
| New | +$393K | 0.04% | 368 |
|